Cargando…
Cellular Signaling Pathway Alterations and Potential Targeted Therapies for Medullary Thyroid Carcinoma
Parafollicular C-cell-derived medullary thyroid cancer (MTC) comprises 3% to 4% of all thyroid cancers. While cytotoxic treatments have been shown to have limited efficacy, targeted molecular therapies that inhibit rearranged during transfection (RET) and other tyrosine kinase receptors that are mai...
Autores principales: | Giunti, Serena, Antonelli, Alessandro, Amorosi, Andrea, Santarpia, Libero |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594951/ https://www.ncbi.nlm.nih.gov/pubmed/23509459 http://dx.doi.org/10.1155/2013/803171 |
Ejemplares similares
-
Medullary Thyroid Carcinoma: Molecular Signaling Pathways and Emerging Therapies
por: Gómez, Karen, et al.
Publicado: (2011) -
Thyroid: Medullary Carcinoma
por: Somnay, Yash R., et al.
Publicado: (2013) -
Medullary Thyroid Carcinoma: Targeted Therapies and Future Directions
por: Pinchot, Scott N., et al.
Publicado: (2009) -
The Management of Medullary Thyroid Carcinoma in the Era of Targeted Therapy
por: Ng-Cheng-Hin, Brian, et al.
Publicado: (2016) -
Medullary carcinoma of the thyroid gland.
por: Russell, C.
Publicado: (1980)